Inactive Instrument

Highlights Soliton, Inc.

Equities

SOLY

US8342511008

Highlights

Unlock all the news: Be the first to know and act before the market!

Allergan plc completed the acquisition of Soliton, Inc. for approximately $570 million.	21-12-15	CI
Soliton Up 12% as Nasdaq Alert Says Sale to AbbVie Is Scheduled to Close Thursday	21-12-14	DJ
Soliton, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Soliton, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Soliton : AbbVie, Soliton Providing FTC Extra Time to Review Proposed Deal	21-07-02	MT
Soliton, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
AbbVie's Allergan Aesthetics to Buy Soliton	21-05-10	DJ
AbbVie : Allergan Aesthetics to Acquire Soliton for $22.60 per Share	21-05-10	MT
Allergan plc entered into a definitive agreement to acquire Soliton, Inc. for approximately $510 million.	21-05-09	CI
Soliton, Inc. Announces Introducing RESONIC™	21-05-05	CI
Soliton, Inc. Receives FDA Clearance of Special 510(K)	21-04-29	CI
Soliton : 501k Application for RESONIC Device Accepted by FDA	21-04-15	MT
Soliton, Inc. Provides Special 510(K) and Commercialization Update	21-04-15	CI
Soliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver Fibrosis	21-03-09	CI
Soliton, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2020	21-03-04	CI
Soliton Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device	21-03-02	CI
Soliton, Inc. Announces RAP Treatment Reduces Effects of Liver Fibrosis by 42% in Animal Study	21-02-23	CI
Soliton, Inc. Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite	21-02-01	CI
Soliton, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-12	CI
Soliton, Inc. Appoints Niquette Hunt to Board of Directors	20-10-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Soliton, Inc.

Equities

SOLY

US8342511008

Highlights

Filters